Is Hologic Stock Outperforming the Dow? Although Hologic has exceeded the Dow over the past year, analysts remain cautious about the stock’s prospects. Barchart · Mar 18
Is Wall Street Bullish or Bearish on Hologic Stock? Though Hologic has outperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects. Barchart · Feb 10
What You Need To Know Ahead of Hologic's Earnings Release Hologic is scheduled to release its first-quarter results soon, with analysts projecting single-digit growth in its bottom line figure. Barchart · Jan 8
Is Hologic Stock Outperforming the Nasdaq? While Hologic has underperformed the Nasdaq over the past year, it has notably outperformed in recent months, but analysts still remain cautious about the stock’s prospects. Barchart · Dec 12, 2025
Hologic Agrees To $18.3 Billion Buyout By Blackstone And TPG Hologic, Inc. (NASDAQ:HOLX) shares are trading higher after the company agreed to be acquired by funds managed by Blackstone Inc. (NYSE:BX) and TPG Inc. (NASDAQ:TPG) for an enterprise value of about $18.3 billion. Benzinga · Oct 21, 2025
What to Expect From Hologic’s Next Quarterly Earnings Report Hologic is set to release its fourth-quarter earnings next month, and analysts are forecasting a solid high-single-digit increase in profits. Barchart · Oct 16, 2025
What Are Wall Street Analysts' Target Price for Hologic Stock? Although Hologic has underperformed the broader market over the past year, it has observed significant gains in recent months, and analysts are turning more optimistic on the stock’s prospects. Barchart · Aug 14, 2025
What to Expect From Hologic's Q3 2025 Earnings Report Hologic is scheduled to report its third-quarter results later this month, and analysts are projecting a marginal decline in profits. Barchart · Jul 15, 2025
How Is Hologic’s Stock Performance Compared to Other Health Care Equipment Stocks? Hologic has outpaced its healthcare equipment peers over the past year, with analysts maintaining a moderately bullish outlook on the stock’s future performance. Barchart · Jun 20, 2025
Here's What to Expect From Hologic’s Next Earnings Report Hologic is scheduled to release its first-quarter results next month, and analysts are projecting single-digit dip in its bottom-line figure. Barchart · Apr 21, 2025
Hologic Stock: Is HOLX Underperforming the Healthcare Sector? Hologic has notably underperformed the healthcare sector over the past year, yet analysts remain moderately bullish on the stock’s prospects. Barchart · Mar 26, 2025
Hologic Stock: Analyst Estimates & Ratings Hologic has observed a significant drop in stock prices recently and analysts are taking a more cautious stance on the company’s prospects. Barchart · Feb 13, 2025
Earnings Preview: What To Expect From Hologic's Report Hologic is scheduled to release its first-quarter results next month, with analysts projecting single-digit growth in its bottom line figure. Barchart · Jan 15, 2025
Is Hologic Stock Underperforming the Dow? Hologic has lagged behind the Dow index over the past three months, yet analysts remain cautiously optimistic about the stock's growth potential. Barchart · Dec 27, 2024
Barchart · Nov 21, 2024 Do Wall Street Analysts Like Hologic Stock? Hologic has underperformed the broader market over the past year, but Wall Street analysts are moderately optimistic about the stock’s future.
Barchart · Oct 28, 2024 Hologic's Quarterly Earnings Preview: What You Need to Know Hologic is poised to announce its fourth-quarter results next month, and analysts predict a double-digit growth in the company’s bottom-line figure.
StockNews.com · Oct 4, 2024 3 Medical Device Stocks With Strong Growth Prospects The medical industry is on the fence of explosive growth, fueled by technological advancements. In this evolving landscape, investors could consider investing in promising medical device stocks like Hologic, Inc. (HOLX), Avanos Medical (AVNS), and Embecta Corp. (EMBC) with solid growth prospects. Learn more….
Barchart · Sep 23, 2024 Is Hologic Stock Outperforming the Nasdaq? Hologic has recently outperformed in the Nasdaq, and Wall Street analysts are moderately bullish about the stock’s prospects.
StockNews.com · Sep 6, 2024 3 MedTech Stocks Revolutionizing Healthcare MedTech stocks are at the forefront of revolutionizing healthcare with the dynamic growth potential of technology. Amid this backdrop, it could be wise to consider investing in companies like Medtronic (MDT), STERIS (STE), and Hologic (HOLX), which are transforming the way healthcare is delivered and tailoring it to individual patient…
Barchart · Aug 20, 2024 Hologic Stock Outlook: Is Wall Street Bullish or Bearish? Hologic has lagged the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.
Barchart · Jul 17, 2024 Hologic's Q3 2024 Earnings: What to Expect Hologic is expected to report its third-quarter earnings results this month, and Wall Street analysts expect a single-digit profit growth.
Benzinga · Apr 29, 2022 Hologic's Return On Capital Employed Overview Pulled from Benzinga Pro data, Hologic (NASDAQ:HOLX) posted Q2 earnings of $455.70 million, an increase from Q1 of 8.71%. Sales dropped to $1.44 billion, a 2.38% decrease between quarters.
Benzinga · Apr 28, 2022 Lower COVID-19 Assay Sales Weighs On Hologic's Q2 Revenue Hologic Inc (NASDAQ:HOLX) reported Q2 FY22 sales of $1.44 billion, down 7% Y/Y, and beating the consensus Wall Street estimate for revenues of $1.29 billion. Lower sales of COVID-19 assays primarily drove a fall in sales. Hologic's global diagnostics business posted revenues of $987.1 million, down 7%. Diagnostics revenues excluding COVID-19 revenues…
Benzinga · Apr 28, 2022 Raymond James Maintains Outperform Rating for Hologic: Here's What You Need To Know Raymond James has decided to maintain its Outperform rating of Hologic (NASDAQ:HOLX) and lower its price target from $84.00 to $83.00. Shares of Hologic are trading down 2.08% over the last 24 hours, at $69.37 per share. A move to $83.00 would account for a 19.65% increase from the current…
Benzinga · Apr 25, 2022 Expert Ratings for Hologic Analysts have provided the following ratings for Hologic (NASDAQ:HOLX) within the last quarter: